vs
EQUITY BANCSHARES INC（EQBK）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
EQUITY BANCSHARES INC的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.8倍（$63.5M vs $35.5M），EQUITY BANCSHARES INC净利率更高（34.8% vs -304.2%，领先339.0%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 28.4%），EQUITY BANCSHARES INC自由现金流更多（$38.1M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 6.6%）
繁荣银行股份有限公司是一家银行控股公司，总部位于德克萨斯州休斯顿，业务覆盖德克萨斯州与俄克拉荷马州中部。截至2019年12月末，公司共运营285家分支网点，其中休斯顿地区（含伍德兰兹）65家，南德克萨斯（含科珀斯克里斯蒂、维多利亚）30家，达拉斯-沃斯堡大都会区75家，布局覆盖德克萨斯州各主要区域。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
EQBK vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $63.5M | $35.5M |
| 净利润 | $22.1M | $-108.1M |
| 毛利率 | — | 59.8% |
| 营业利润率 | 41.7% | -304.8% |
| 净利率 | 34.8% | -304.2% |
| 营收同比 | 28.4% | 681.7% |
| 净利润同比 | 30.0% | 39.6% |
| 每股收益（稀释后） | $1.07 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $63.5M | $35.5M | ||
| Q3 25 | $18.0M | $5.2M | ||
| Q2 25 | $58.4M | $19.2M | ||
| Q1 25 | $60.6M | $14.7M | ||
| Q4 24 | $58.3M | $4.5M | ||
| Q3 24 | $55.3M | $26.1M | ||
| Q2 24 | $55.4M | $14.4M | ||
| Q1 24 | $55.9M | $13.8M |
| Q4 25 | $22.1M | $-108.1M | ||
| Q3 25 | $-29.7M | $-162.3M | ||
| Q2 25 | $15.3M | $-171.9M | ||
| Q1 25 | $15.0M | $-202.5M | ||
| Q4 24 | $17.0M | $-178.9M | ||
| Q3 24 | $19.9M | $-95.8M | ||
| Q2 24 | $11.7M | $-97.5M | ||
| Q1 24 | $14.1M | $-91.4M |
| Q4 25 | — | 59.8% | ||
| Q3 25 | — | -183.8% | ||
| Q2 25 | — | -4.9% | ||
| Q1 25 | — | -48.0% | ||
| Q4 24 | — | -181.4% | ||
| Q3 24 | — | 53.7% | ||
| Q2 24 | — | 36.2% | ||
| Q1 24 | — | 19.1% |
| Q4 25 | 41.7% | -304.8% | ||
| Q3 25 | -207.2% | -3327.6% | ||
| Q2 25 | 31.5% | -916.8% | ||
| Q1 25 | 31.1% | -1297.9% | ||
| Q4 24 | 35.0% | -4042.4% | ||
| Q3 24 | 43.1% | -377.1% | ||
| Q2 24 | 29.4% | -697.4% | ||
| Q1 24 | 31.8% | -698.4% |
| Q4 25 | 34.8% | -304.2% | ||
| Q3 25 | -164.7% | -3135.3% | ||
| Q2 25 | 26.1% | -894.2% | ||
| Q1 25 | 24.8% | -1373.3% | ||
| Q4 24 | 29.1% | -3935.5% | ||
| Q3 24 | 35.9% | -367.5% | ||
| Q2 24 | 21.1% | -676.6% | ||
| Q1 24 | 25.2% | -662.4% |
| Q4 25 | $1.07 | $-0.17 | ||
| Q3 25 | $-1.55 | $-0.36 | ||
| Q2 25 | $0.86 | $-0.41 | ||
| Q1 25 | $0.85 | $-0.50 | ||
| Q4 24 | $1.06 | $-0.56 | ||
| Q3 24 | $1.28 | $-0.34 | ||
| Q2 24 | $0.76 | $-0.40 | ||
| Q1 24 | $0.90 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $743.3M |
| 总债务越低越好 | $443.2M | $9.6M |
| 股东权益账面价值 | $732.1M | $1.1B |
| 总资产 | $6.4B | $1.5B |
| 负债/权益比越低杠杆越低 | 0.61× | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | — | $743.3M | ||
| Q3 25 | — | $659.8M | ||
| Q2 25 | — | $525.1M | ||
| Q1 25 | — | $500.5M | ||
| Q4 24 | — | $594.4M | ||
| Q3 24 | — | $427.6M | ||
| Q2 24 | — | $474.3M | ||
| Q1 24 | — | $296.3M |
| Q4 25 | $443.2M | $9.6M | ||
| Q3 25 | $486.9M | $11.9M | ||
| Q2 25 | $448.4M | $14.2M | ||
| Q1 25 | $376.9M | $16.4M | ||
| Q4 24 | $312.8M | $19.0M | ||
| Q3 24 | $437.5M | $20.5M | ||
| Q2 24 | $391.7M | $22.9M | ||
| Q1 24 | $367.1M | — |
| Q4 25 | $732.1M | $1.1B | ||
| Q3 25 | $711.9M | $1.0B | ||
| Q2 25 | $635.6M | $919.1M | ||
| Q1 25 | $617.3M | $933.9M | ||
| Q4 24 | $592.9M | $1.0B | ||
| Q3 24 | $504.0M | $524.6M | ||
| Q2 24 | $461.4M | $584.4M | ||
| Q1 24 | $456.8M | $401.2M |
| Q4 25 | $6.4B | $1.5B | ||
| Q3 25 | $6.4B | $1.4B | ||
| Q2 25 | $5.4B | $1.3B | ||
| Q1 25 | $5.4B | $1.3B | ||
| Q4 24 | $5.3B | $1.4B | ||
| Q3 24 | $5.4B | $726.5M | ||
| Q2 24 | $5.2B | $775.9M | ||
| Q1 24 | $5.2B | $557.8M |
| Q4 25 | 0.61× | 0.01× | ||
| Q3 25 | 0.68× | 0.01× | ||
| Q2 25 | 0.71× | 0.02× | ||
| Q1 25 | 0.61× | 0.02× | ||
| Q4 24 | 0.53× | 0.02× | ||
| Q3 24 | 0.87× | 0.04× | ||
| Q2 24 | 0.85× | 0.04× | ||
| Q1 24 | 0.80× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $51.4M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $38.1M | $-47.3M |
| 自由现金流率自由现金流/营收 | 60.0% | -133.1% |
| 资本支出强度资本支出/营收 | 20.9% | 3.5% |
| 现金转化率经营现金流/净利润 | 2.33× | — |
| 过去12个月自由现金流最近4个季度 | $88.8M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $51.4M | $-46.1M | ||
| Q3 25 | $8.5M | $-117.4M | ||
| Q2 25 | $28.3M | $-76.4M | ||
| Q1 25 | $21.7M | $-132.0M | ||
| Q4 24 | $73.8M | $-115.4M | ||
| Q3 24 | $23.5M | $-59.2M | ||
| Q2 24 | $16.0M | $-82.2M | ||
| Q1 24 | $12.6M | $-102.3M |
| Q4 25 | $38.1M | $-47.3M | ||
| Q3 25 | $4.5M | $-117.6M | ||
| Q2 25 | $26.0M | $-79.6M | ||
| Q1 25 | $20.2M | $-133.8M | ||
| Q4 24 | $65.4M | $-116.7M | ||
| Q3 24 | $19.7M | $-63.8M | ||
| Q2 24 | $15.2M | $-83.4M | ||
| Q1 24 | $10.6M | $-109.0M |
| Q4 25 | 60.0% | -133.1% | ||
| Q3 25 | 24.7% | -2272.5% | ||
| Q2 25 | 44.5% | -413.9% | ||
| Q1 25 | 33.3% | -907.4% | ||
| Q4 24 | 112.1% | -2567.7% | ||
| Q3 24 | 35.6% | -244.6% | ||
| Q2 24 | 27.4% | -578.5% | ||
| Q1 24 | 19.0% | -789.9% |
| Q4 25 | 20.9% | 3.5% | ||
| Q3 25 | 22.3% | 4.7% | ||
| Q2 25 | 3.9% | 16.4% | ||
| Q1 25 | 2.4% | 12.4% | ||
| Q4 24 | 14.6% | 28.6% | ||
| Q3 24 | 6.8% | 17.5% | ||
| Q2 24 | 1.5% | 8.2% | ||
| Q1 24 | 3.6% | 48.2% |
| Q4 25 | 2.33× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 1.85× | — | ||
| Q1 25 | 1.44× | — | ||
| Q4 24 | 4.35× | — | ||
| Q3 24 | 1.18× | — | ||
| Q2 24 | 1.37× | — | ||
| Q1 24 | 0.90× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
